About Us
Pipeline
News
Contact Us
About Us
Pipeline
News
Contact Us
News
2024/03/20
Antennova Completes First Dosing Cohort for Anti-CD24 mAb, ATN-031, in the Phase I PERFORM Study
more
<
1
>